AstraZeneca leads FTSE 100 lower
Shares in drugs giant AstraZeneca have fallen following a report that its chief executive, Pascal Soriot, is to leave to company to join Israel-based Teva Pharmaceutical Industries.The report, on the Calcalist financial news website, pushed AstraZeneca’s share